$1.25
-0.02-1.57%
At close: -
$1.24
-0.01-0.80%
After Hours: Apr 4, 7:59 PM EDT
Comments
Loading...
Sonnet BioTherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SONN | Benzinga
Sonnet BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-6.320
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.00M
Analyze the earnings history of Sonnet BioTherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics | $0.56 | -$6.32 | — | — | $0.00 | — | — | — | 05/13/2025 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$2.46 | -$1.39 | -$1.56 | -12.23% | $18.63K | — | $0.00 | — | 02/13/2025 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$6.24 | -$5.04 | -$3.67 | 27.18% | $37.26K | $30.00K | $0.00 | -100.00% | 12/17/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$23.60 | -$6.08 | -$5.60 | 7.89% | $36.85K | $30.00K | $0.00 | -100.00% | 08/14/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$60.40 | $1.04 | $0.56 | -46.15% | $36.45K | $10.00K | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$140.80 | -$7.20 | -$2.48 | 65.56% | $37.26K | $20.00K | $18.63K | -6.87% | 02/14/2024 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$292.16 | -$7.20 | -$6.24 | 13.33% | $62.75K | $20.00K | $37.26K | 86.27% | 12/14/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$320.32 | -$54.56 | -$22.88 | 58.06% | $62.07K | — | $36.85K | — | 08/14/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$336.16 | — | -$59.84 | — | $95.32K | — | $36.45K | — | 05/10/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$246.40 | — | -$140.80 | — | $129.80K | — | $37.26K | — | 02/13/2023 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$221.76 | — | -$292.16 | — | $0.00 | — | $62.75K | — | 12/15/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$665.28 | — | -$320.32 | — | $0.00 | — | $62.07K | — | 08/15/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$788.48 | — | -$344.96 | — | $0.00 | — | $95.32K | — | 05/10/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$837.76 | — | -$246.40 | — | $0.00 | — | $129.80K | — | 02/08/2022 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$11.65K | — | -$221.76 | — | $0.00 | — | $0.00 | — | 12/17/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$1.08K | — | -$665.28 | — | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$123.20 | — | -$788.48 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | -$1.08K | — | -$837.76 | — | — | — | $0.00 | — | 02/16/2021 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$11.65K | — | — | — | $0.00 | — | 12/17/2020 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$1.08K | — | — | — | $0.00 | — | 08/14/2020 | Get Alert |
| SONN | Sonnet BioTherapeutics | — | — | -$123.20 | — | — | — | $0.00 | — | 05/18/2020 | Get Alert |
Sonnet BioTherapeutics (SONN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-02-13 | $-1.56 | $-1.39 | -12.2 % |
| Q4 | 2024-12-17 | $-3.67 | $-5.04 | 27.2 % |
| Q3 | 2024-08-14 | $-5.60 | $-6.08 | 7.89 % |
| Q2 | 2024-05-14 | $0.56 | $1.04 | -46.2 % |
Sonnet BioTherapeutics (SONN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-12-17 | $0 | $30.00K | -100.0 % |
| Q3 | 2024-08-14 | $0 | $30.00K | -100.0 % |
| Q2 | 2024-05-14 | $0 | $10.00K | -100.0 % |
| Q1 | 2024-02-14 | $18.63K | $20.00K | -6.87 % |
FAQ
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics (SONN) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on February 13, 2025 for Q1.
What were the latest earnings per share (EPS) for Sonnet BioTherapeutics (NASDAQ:SONN)?
The Actual EPS was $-1.56, which missed the estimate of $-1.39.
What were Sonnet BioTherapeutics’s (NASDAQ:SONN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.